Epinephrine (INN) (IPA: [ˌɛpɪˈnɛfrən]) or
adrenaline (European Pharmacopoeia and BAN) (IPA: [əˈdrɛnələn]), sometimes spelled "epinephrin" or "adrenalin" respectively, is a
hormone when carried in the blood and a neurotransmitter when it is released across a neuronal synapse. It is a catecholamine, a sympathomimetic monoamine derived from the
amino acids phenylalanine and tyrosine. The Latin roots ad-+renes and the Greek roots epi-+nephros both literally mean "on/to the kidney" (referring to the adrenal gland, which sits atop the kidneys and
secretes epinephrine). Epinephrine is sometimes shortened to epi or to EP in medical jargon.
History
In May 1886, William Bates reported the discovery of a substance produced by the
adrenal gland in the New York Medical Journal. Epinephrine was isolated and
identified in 1895 by Napoleon Cybulski, a Polish
physiologist. The discovery was repeated in 1897 by John
Jacob Abel.[1]
Jokichi Takamine, a Japanese chemist, independently discovered the same hormone in
1900.[2][3]
It was first artificially synthesized in 1904 by Friedrich Stolz.
Actions in the body
Adrenaline Ampulle, 1 mg (Suprarenin
®)
Epinephrine is a "fight or flight" hormone which is released from the
adrenal glands when danger threatens or in an emergency. When secreted into the bloodstream, it rapidly prepares the body for
action in emergency situations. The hormone boosts the supply of oxygen and glucose to the brain and muscles, while suppressing
other non-emergency bodily processes (digestion in particular).
Epinephrine plays a central role in the short-term stress reaction—the
physiological response to threatening, exciting, or environmental stressor conditions such as
high noise levels or bright light
(see Fight-or-flight response). It is secreted by the adrenal medulla. When released into the bloodstream, epinephrine binds to multiple receptors and has numerous effects throughout the body. It increases heart rate and stroke volume, dilates the pupils, and constricts arterioles in the skin and gut while dilating arterioles
in leg muscles. It elevates the blood sugar level by increasing catalysis of glycogen to glucose in the liver, and at the same time begins the breakdown of
lipids in fat cells. Like some other stress hormones,
epinephrine has a suppressive effect on the immune system.[4]
Although epinephrine does not have any psychoactive effects, stress or arousal also releases norepinephrine in the brain. Norepinephrine has similar actions in the body, but is also
psychoactive.
Epinephrine is used as a drug to treat cardiac
arrest and other cardiac dysrhythmias resulting in diminished or absent
cardiac output; its action is to increase peripheral resistance via α1-adrenoceptor vasoconstriction, so that blood
is shunted to the body's core, and the β1-adrenoceptor response which is
increased cardiac rate and output (the speed and pronouncement of heart beats). This beneficial action comes with a significant
negative consequence—increased cardiac irritability—which may lead to additional complications immediately following an otherwise
successful resuscitation. Alternatives to this treatment include vasopressin, a powerful
antidiuretic which also increases peripheral vascular resistance leading to blood shunting
via vasoconstriction, but without the attendant increase in myocardial irritability.[4]
Because of its suppressive effect on the immune system, epinephrine is used to treat anaphylaxis and sepsis. Allergy patients undergoing immunotherapy may receive an epinephrine rinse before the allergen extract is administered, thus reducing
the immune response to the administered allergen. It is also used as a bronchodilator for
asthma if specific beta2-adrenergic receptor agonists are unavailable or ineffective. Adverse
reactions to epinephrine include palpitations, tachycardia, anxiety, headache, tremor, hypertension, and acute
pulmonary edema.[5]
Biosynthesis
Epinephrine is synthesized from
norepinephrine in a synthetic pathway shared by all
catecholamines.
Epinephrine is synthesized from norepinephrine in a synthetic pathway shared by all
catecholamines, including L-dopa, dopamine, norepinephrine, and epinephrine.
Epinephrine is synthesized via methylation of the primary distal amine of norepinephrine by phenylethanolamine
N-methyltransferase (PNMT) in the cytosol of adrenergic
neurons and cells of the adrenal medulla (so-called chromaffin cells). PNMT is only found in the cytosol of cells of adrenal medullary cells. PNMT uses
S-adenosylmethionine (SAMe) as a cofactor to donate the methyl group to norepinephrine, creating epinephrine.
For norepinephrine to be acted upon by PNMT in the cytosol, it must first be shipped out of granules of the chromaffin cells. This may occur via the catecholamine-H+ exchanger
VMAT1. VMAT1 is also responsible for transporting newly synthesized epinephrine from the cytosol
back into chromaffin granules in preparation for release.
Regulation
Epinephrine synthesis is solely under the control of the central nervous
system (CNS). Several levels of regulation dominate epinephrine synthesis.
Adrenocorticotropic hormone (ACTH) and the sympathetic nervous system stimulate the synthesis of epinephrine precursors by enhancing the
activity of enzymes involved in catecholamine synthesis. The specific enzymes are
tyrosine hydroxylase in the synthesis of dopa and
enzyme dopamine-β-hydroxylase in the synthesis of norepinephrine.
ACTH also stimulates the adrenal cortex to release cortisol, which increases the expression of PNMT in chromaffin cells, enhancing epinephrine synthesis.
The sympathetic nervous system, acting via splanchnic nerves to the adrenal
medulla, stimulates the release of epinephrine. Acetylcholine released by preganglionic
sympathetic fibers of these nerves acts on nicotinic acetylcholine
receptors, causing cell depolarization and an influx of calcium through voltage-gated calcium channels. Calcium triggers the exocytosis of chromaffin granules
and thus the release of epinephrine (and norepinephrine) into the bloodstream.
Unlike many other hormones, epinephrine (as with other catecholamines) does not exert any negative feedback to down-regulate its own synthesis.
A pheochromocytoma is a tumor of the adrenal gland (or, rarely, the ganglia of the
sympathetic nervous system), which results in the uncontrolled secretion of
catecholamines, usually epinephrine.
In liver cells, epinephrine binds to the β-Adrenergic receptor which changes conformation and helps Gs, a G protein, exchange
GDP to GTP. This trimeric G protein dissociates to Gs alpha and Gs beta/gamma subunits. Ga alpha binds to adenyl cyclase thus
converting ATP into Cyclic AMP. Cyclic AMP binds to the regulatory subunit of Protein Kinase A: Protein kinase A phosphorylates
Phosphorylase Kinase. Meanwhile, Gs beta/gamma binds to the calcium channel and allows calcium ions to enter the cytoplasm.
Calcium ions bind to calmodulin proteins, a protein present in all eukaryotic cells, which then binds to Phosphorylase Kinase and
finishes its activation. Phosphorylase Kinase phosphorylates Phosphorylase which then phosphorylates glycogen and converts it to
glucose-6-phosphate.
Pharmacology
Epinephrine's actions are mediated through adrenergic receptors:
- Epinephrine also activates β-adrenergic receptors of the liver and muscle cells, thereby activating the
adenylate cyclase signaling pathway, which will in turn increase glycogenolysis.
β2 receptors are found primarily in skeletal muscle blood vessels where
they trigger vasodilation. However, α-adrenergic receptors are found in most
smooth muscles and splanchnic vessels, and epinephrine
triggers vasoconstriction in those vessels.
Thus, depending on the patient, administration of epinephrine may raise or lower blood pressure, depending
whether or not the net increase or decrease in peripheral resistance can balance the positive inotropic and chronotropic effects of epinephrine on the heart, effects
which respectively increase the contractility and rate
of the heart.
Terminology
Although widely referred to as adrenaline outside of the US, and the lay public
worldwide, the USAN and INN for this chemical is epinephrine because adrenaline bore too much
similarity to the Parke, Davis & Co trademark adrenalin (without the "e") which was registered in the US. The
BAN and EP term for this chemical
is adrenaline, and is indeed now one of the few differences between the INN and BAN systems of names.
Amongst US health professionals, the term epinephrine is used over adrenaline. However, it should be noted that
universally, pharmaceuticals that mimic the effects of epinephrine are called adrenergics, and receptors for epinephrine
are called adrenoceptors.
Isomers
Natural epinephrine is the (R)-(−)-L-epinephrine stereoisomer.
Autoinjectors
Epinephrine is now also used in EpiPens and Twinjects.
EpiPens are long narrow auto-injectors that administer epinephrine, Twinjects are similar but contain two doses of epinephrine.
Though both EpiPen and Twinject are trademark names, common usage of the terms are drifting toward the
generic context of any epinephrine autoinjector.
See also
References
Notes
- ^ Aronson JK (2000). "Where name and image meet" -
the argument for "adrenaline". British Medical Journal 320, 506-9.
- ^ Yamashima T (2003). "Jokichi Takamine
(1854-1922), the samurai chemist, and his work on adrenalin". J Med Biogr 11 (2): 95-102. PMID
12717538.
- ^ Bennett M (1999). "One hundred years of
adrenaline: the discovery of autoreceptors". Clin Auton Res 9 (3): 145-59. PMID 10454061.
- ^ a b Epinephrine - Online Medical Dictionary
- ^ About.com - "The
Definition of Epinephrine"
General references
- Walter F. Boron, Emile L. Boulpaep (2005). Medical Physiology: A Cellular And
Molecular Approach. Philadelphia, PA: Elsevier/Saunders. ISBN 1-4160-2328-3.
|
Endocrine system: hormones/endocrine glands (Peptide hormones, Steroid hormones) |
| Hypothalamic-pituitary |
Hypothalamus:
TRH, CRH ,
GnRH, GHRH,
somatostatin, dopamine - Posterior pituitary: vasopressin, oxytocin - Anterior pituitary: α (FSH, LH, TSH), GH, prolactin, POMC
(ACTH, MSH,
endorphins, lipotropin) |
| Adrenal
axis |
Adrenal
medulla: epinephrine, norepinephrine -
Adrenal cortex: aldosterone, cortisol, DHEA |
| Thyroid
axis |
Thyroid:
thyroid hormone (T3 and
T4) - calcitonin - Parathyroid: PTH |
| Gonadal
axis |
Testis: testosterone, AMH, inhibin - Ovary:
estradiol, progesterone, inhibin/activin, relaxin (pregnancy) |
| Other end. glands |
Pancreas:
glucagon, insulin, somatostatin - Pineal gland: melatonin |
| Non-end. glands |
Placenta: hCG, HPL, estrogen, progesterone - Kidney: renin,
EPO, calcitriol, prostaglandin - Heart atrium: ANP - Stomach: gastrin, ghrelin - Duodenum:
CCK, GIP, secretin, motilin, VIP
- Ileum: enteroglucagon - Adipose tissue: leptin, adiponectin, resistin - Thymus:
Thymosin - Thymopoietin - Skeleton: Osteocalcin - Liver/other: Insulin-like growth factor (IGF-1, IGF-2) |
| Target-derived |
NGF,
BDNF, NT-3 |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)